Thymopentine (BioDeep_00000857406)
代谢物信息卡片
Thymopentine
化学式: C30H49N9O9 (679.3653064)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N
InChI: InChI=1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24?/m0/s1
描述信息
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant
D007155 - Immunologic Factors
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Si-Jia Peng, Ya Feng, Xuan Li, Xi-Xi Wang, Yu Wang, Bu-Tian Zhou, Ye Liu, Te Liu, Yun-Cheng Wu. Thymopentin (TP-5) prevents lipopolysaccharide-induced neuroinflammation and dopaminergic neuron injury by inhibiting the NF-κB/NLRP3 signaling pathway.
International immunopharmacology.
2023 Jun; 119(?):110109. doi:
10.1016/j.intimp.2023.110109. [PMID: 37121113] - Mengyang Liu, Darren Svirskis, Thomas Proft, Jacelyn Loh, Shuo Chen, Dali Kang, Jingyuan Wen. Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations.
International journal of pharmaceutics.
2022 Sep; 625(?):122123. doi:
10.1016/j.ijpharm.2022.122123. [PMID: 35995317] - Te Liu, Fangyuan Jing, Peirong Huang, Zixiang Geng, Jianghong Xu, Jiahui Li, Danping Chen, Ying Zhu, Zhenxin Wang, Willian Huang, Chuan Chen. Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let-7 family microRNAs.
Cell proliferation.
2021 Aug; 54(8):e13089. doi:
10.1111/cpr.13089. [PMID: 34180104] - Xueqin Zhu, Jianjun Liu, Hao Pan, Zixiang Geng, William Huang, Te Liu, Bimeng Zhang. Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway.
International journal of medical sciences.
2021; 18(15):3544-3555. doi:
10.7150/ijms.61975. [PMID: 34522181] - Qiuhua Cao, Xinghua Gao, Yanting Lin, Chongxiu Yue, Yue Wang, Fei Quan, Zixuan Zhang, Xiaoxuan Liu, Yuan Lu, Yanling Zhan, Hongbao Yang, Xianjing Li, Di Qin, Lutz Birnbaumer, Kun Hao, Yong Yang. Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes.
Theranostics.
2019; 9(25):7490-7505. doi:
10.7150/thno.35015. [PMID: 31695782] - Song-Gyu Ra, Teruo Miyazaki, Ryo Kojima, Shoichi Komine, Keisuke Ishikura, Kentaro Kawanaka, Akira Honda, Yasushi Matsuzaki, Hajime Ohmori. Effect of BCAA supplement timing on exercise-induced muscle soreness and damage: a pilot placebo-controlled double-blind study.
The Journal of sports medicine and physical fitness.
2018 Nov; 58(11):1582-1591. doi:
10.23736/s0022-4707.17.07638-1. [PMID: 28944645] - Shiqi Lin, Bingzhen Cai, Guilan Quan, Tingting Peng, Gangtao Yao, Chune Zhu, Qiaoli Wu, Hao Ran, Xin Pan, Chuanbin Wu. Novel strategy for immunomodulation: Dissolving microneedle array encapsulating thymopentin fabricated by modified two-step molding technology.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
2018 Jan; 122(?):104-112. doi:
10.1016/j.ejpb.2017.10.011. [PMID: 29042238] - Yuanyan Tan, Wei Wang, Chunlei Wu, Zhengyin Pan, Guiyang Yao, Lijing Fang, Wu Su. Myristic acid-modified thymopentin for enhanced plasma stability and immune-modulating activity.
International immunopharmacology.
2017 Jun; 47(?):88-94. doi:
10.1016/j.intimp.2017.03.025. [PMID: 28365509] - Cao Xiaojing, Li Yanfang, Guo Yanqing, Cao Fangfang. Thymopentin improves cardiac function in older patients with chronic heart failure.
Anatolian journal of cardiology.
2017 Jan; 17(1):24-30. doi:
10.14744/anatoljcardiol.2016.6692. [PMID: 27564775] - Ying Zhong, Liyu Chen, Yu Zhang, Wenhao Li, Xun Sun, Tao Gong, Zhirong Zhang. Vesicular phospholipid gels using low concentrations of phospholipids for the sustained release of thymopentin: pharmacokinetics and pharmacodynamics.
Die Pharmazie.
2013 Oct; 68(10):811-5. doi:
". [PMID: 24273885] - Li-Na Han, Shu-Li Guo, Tie-Ling Li, Guo-Lei Ding, Ya-Jing Zhang, Jin-Ling Ma. Effect of immune modulation therapy on cardiac function and T-bet/GATA-3 gene expression in aging male patients with chronic cardiac insufficiency.
Immunotherapy.
2013 Feb; 5(2):143-53. doi:
10.2217/imt.12.139. [PMID: 23413906] - Bo Yang, Xue-chun Lu, Rui-li Yu, Xiao-hua Chi, Yang Liu, Yao Wang, Han-ren Dai, Hong-li Zhu, Li-li Cai, Wei-dong Han. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial.
Hematological oncology.
2012 Sep; 30(3):115-22. doi:
10.1002/hon.1012. [PMID: 22972689] - Jiao Zuo, Tao Gong, Xun Sun, Yuan Huang, Qiang Peng, Zhirong Zhang. Multivesicular liposomes for the sustained release of thymopentin: stability, pharmacokinetics and pharmacodynamics.
Die Pharmazie.
2012 Jun; 67(6):507-12. doi:
NULL. [PMID: 22822538] - Qingfang Meng, Zhihang Chen, Jinjing Che, Yiping Lu, Huanzhang Wang, Chengqi Shan, Yunan Hou, Hongjiao Shi, Yangjun Zhang, Junying Wei, Xiaohong Qian, Hongwei Peng, Yuanguo Cheng. An LC-MS/MS assay to determine plasma pharmacokinetics of cyclic thymic hexapeptide (cTP6) in rhesus monkeys.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
2011 Oct; 879(27):2902-8. doi:
10.1016/j.jchromb.2011.08.021. [PMID: 21903490] - Rui Yang, Renchao Gao, Fang Li, Haibing He, Xing Tang. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process.
Drug development and industrial pharmacy.
2011 Feb; 37(2):139-48. doi:
10.3109/03639045.2010.497151. [PMID: 20578879] - Yan-Zhen Li, Xun Sun, Tao Gong, Jie Liu, Jiao Zuo, Zhi-Rong Zhang. Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles.
Pharmaceutical research.
2010 Sep; 27(9):1977-86. doi:
10.1007/s11095-010-0201-z. [PMID: 20625801] - Rui Yang, Ren-Chao Gao, Cui-Fang Cai, Hui Xu, Fang Li, Hai-Bing He, Xing Tang. Preparation of gel-core-solid lipid nanoparticle: a novel way to improve the encapsulation of protein and peptide.
Chemical & pharmaceutical bulletin.
2010 Sep; 58(9):1195-202. doi:
10.1248/cpb.58.1195. [PMID: 20823599] - Qiang Chi, Xiangyang Xie, Jianwei Zhang, Yuan Yang, Zhiping Li, Xingguo Mei. Synthesis, characterization and biological activities of thymopentin ethyl ester.
Die Pharmazie.
2008 Nov; 63(11):784-7. doi:
NULL. [PMID: 19069236] - Demin Gao, Xulong Zhang, Jian Zhang, Jichao Cao, Fengshan Wang. Expression of thymosin alpha1-thymopentin fusion peptide in Pichia pastoris and its characterization.
Archives of pharmacal research.
2008 Nov; 31(11):1471-6. doi:
10.1007/s12272-001-2132-z. [PMID: 19023544] - Yu-huan Jiao, Kao-xiang Sun, Hong-jie Mu, Tao Wang, Dong-gang Yao, Zhi-zhao Yuan. [Preparation of sustained release multivesicular liposome for thymopentin and preliminary study on its pharmacokinetics in rats].
Yao xue xue bao = Acta pharmaceutica Sinica.
2008 Jul; 43(7):756-60. doi:
NULL. [PMID: 18819482] - Yashu Yin, Dawei Chen, Mingxi Qiao, Zhe Lu, Haiyang Hu. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Journal of controlled release : official journal of the Controlled Release Society.
2006 Dec; 116(3):337-45. doi:
10.1016/j.jconrel.2006.09.015. [PMID: 17097180] - F Fabrizi, V Dixit, P Martin. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
Alimentary pharmacology & therapeutics.
2006 Jun; 23(11):1559-66. doi:
10.1111/j.1365-2036.2006.02923.x. [PMID: 16696803] - Shanling Tang, Wenli Shi, Wei Zhang. [Therapeutic effects of Lamivudine in combination with Thymopentin on chronic hepatitis B].
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.
2002 Dec; 16(4):385-7. doi:
NULL. [PMID: 12665914] - G Noh, K Y Lee. Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study.
Cytokine.
2001 Jan; 13(2):124-8. doi:
10.1006/cyto.2000.0807. [PMID: 11145854] - S Guérin, B Mari, E Fernandez, N Belhacene, M L Toribio, P Auberger. CD10 is expressed on human thymic epithelial cell lines and modulates thymopentin-induced cell proliferation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
1997 Oct; 11(12):1003-11. doi:
10.1096/fasebj.11.12.9337153. [PMID: 9337153] - J I DeGraw, R G Almquist, C K Hiebert, A K Judd, L Dousman, R L Smith, W R Waud, I Uchida. Stabilized analogs of thymopentin. 2. 1,2- and 3,4-ketomethylene pseudopeptides.
Journal of medicinal chemistry.
1997 Jul; 40(15):2398-406. doi:
10.1021/jm9508043. [PMID: 9240354] - J I DeGraw, R G Almquist, C K Hiebert, W T Colwell, J Crase, T Hayano, A K Judd, L Dousman, R L Smith, W R Waud, I Uchida. Stabilized analogs of thymopentin. 1. 4,5-Ketomethylene pseudopeptides.
Journal of medicinal chemistry.
1997 Jul; 40(15):2386-97. doi:
10.1021/jm950803a. [PMID: 9240353] - L M Tarasenko, K S Neporada, I M Skrypnyk, V Ie Klusha. [The typological characteristics of the stress activation of lipid peroxidation and its correction by thymopentin].
Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994).
1997; 43(1-2):113-6. doi:
". [PMID: 9221111] - M Braga, L Gianotti, O Gentilini, C Fortis, G Consogno, V Di Carlo. Thymopentin modulates Th1 and Th2 cytokine response and host survival in experimental injury.
The Journal of surgical research.
1996 May; 62(2):197-200. doi:
10.1006/jsre.1996.0195. [PMID: 8632639] - T C Merigan, R L Hirsch, A C Fisher, L A Meyerson, G Goldstein, M A Winters. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
AIDS (London, England).
1996 Feb; 10(2):159-65. doi:
10.1097/00002030-199602000-00005. [PMID: 8838703] - G Goldstein, M A Conant, G Beall, H A Grossman, J E Galpin, G Blick, L H Calabrese, R L Hirsch, A Fisher, P Stampone. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
1995 Mar; 8(3):279-88. doi:
10.1097/00042560-199503010-00009. [PMID: 7859140] - P Raiola, M Manzo, A Saggese, G Tomasino, T Cicchella, M Rambaldi, M Pisano, B Lizza, A F Perna. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
1995; 10 Suppl 6(?):48-50. doi:
10.1093/ndt/10.supp6.48. [PMID: 8524495] - L Di Lauro, P Del Medico, S Carpano, A Cancrini, T Gionfra, P Vici, M Rosselli, M Lopez. Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.
Tumori.
1995 Jan; 81(1):42-4. doi:
10.1177/030089169508100110. [PMID: 7754540] - F Nicoletti, P Zaccone, G Magro, W Barcellini, V Cavallaro, G Belli, C Cocuzza, R di Marco, P L Meroni. The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouse.
Scandinavian journal of immunology.
1994 Nov; 40(5):549-56. doi:
10.1111/j.1365-3083.1994.tb03503.x. [PMID: 7973460] - G Fattovich, G Giustina, A Alberti, M Guido, P Pontisso, S Favarato, L Benvegnù, A Ruol. A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B.
Journal of hepatology.
1994 Sep; 21(3):361-6. doi:
10.1016/s0168-8278(05)80314-9. [PMID: 7836705] - F Eichler, G R Krueger. Effects of non-specific immunostimulants (echinacin, isoprinosine and thymus factors) on the infection and antigen expression in herpesvirus-6 exposed human lymphoid cells.
In vivo (Athens, Greece).
1994 Jul; 8(4):565-75. doi:
". [PMID: 7534493] - M J Stiller, J L Shupack, C Kenny, L Jondreau, D E Cohen, N A Soter. A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis.
Journal of the American Academy of Dermatology.
1994 Apr; 30(4):597-602. doi:
10.1016/s0190-9622(94)70068-0. [PMID: 8157786] - M Braga, E Costantini, A Di Francesco, L Gianotti, P Baccari, V Di Carlo. Impact of thymopentin on the incidence and severity of postoperative infection: a randomized controlled trial.
The British journal of surgery.
1994 Feb; 81(2):205-8. doi:
10.1002/bjs.1800810216. [PMID: 8156337] - M P Iurato, A Chiarenza, N Barbera, G Cantarella, L Lempereur, F Drago, U Scapagini, R Bernardini. Thymic factors influence on behavior in rodents.
Pharmacology, biochemistry, and behavior.
1993 Mar; 44(3):665-71. doi:
10.1016/0091-3057(93)90184-u. [PMID: 8383855] - A Markewitz, E Faist, S Lang, S Endres, D Fuchs, B Reichart. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation.
The Journal of thoracic and cardiovascular surgery.
1993 Jan; 105(1):15-24. doi:
10.1016/s0022-5223(19)33842-5. [PMID: 8419695] - R Bräuer, A J Egg, S Henzgen, J Kriegsmann, K Thoss. The effects of immunomodulatory thymic and splenic peptides and cyclosporin A on antigen-induced arthritis in the rat.
Agents and actions.
1993; 38 Spec No(?):C95-7. doi:
10.1007/bf01991149. [PMID: 8317333] - M G Bernengo, A Appino, M Bertero, M Novelli, M T Fierro, G C Doveil, F Lisa. Thymopentin in Sézary syndrome.
Journal of the National Cancer Institute.
1992 Sep; 84(17):1341-6. doi:
10.1093/jnci/84.17.1341. [PMID: 1386633] - S Angioni, G Iori, M Cellini, S Sardelli, F Massolo, F Petraglia, A R Genazzani. Acute beta-interferon or thymopentin administration increases plasma growth hormone and cortisol levels in children.
Acta endocrinologica.
1992 Sep; 127(3):237-41. doi:
10.1530/acta.0.1270237. [PMID: 1414149] - K H Hsieh, M F Shaio, T N Liao. Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations.
Archives of disease in childhood.
1992 Sep; 67(9):1095-102. doi:
10.1136/adc.67.9.1095. [PMID: 1329673] - M Braga, A Di Francesco, L Gianotti, P Baccari, V Di Carlo. [Perioperative administration of thymopentin for the prevention of infections in oncologic surgery].
Minerva chirurgica.
1992 Feb; 47(3-4):125-30. doi:
NULL. [PMID: 1565267] - J L Ebersole, K S Kornman. Systemic antibody responses to oral microorganisms in the cynomolgus monkey: development of methodology and longitudinal responses during ligature-induced disease.
Research in immunology.
1991 Nov; 142(9):829-39. doi:
10.1016/0923-2494(91)90128-6. [PMID: 1665573] - E Faist, A Markewitz, D Fuchs, S Lang, S Zarius, F W Schildberg, H Wachter, B Reichart. Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.
Annals of surgery.
1991 Sep; 214(3):264-73; discussion 274. doi:
10.1097/00000658-199109000-00009. [PMID: 1929608] - G Amiconi, I Ilardi, G Sebastiani, S Shiddo. Reinfection of Somali children with Trichuris trichuria: a reply.
Transactions of the Royal Society of Tropical Medicine and Hygiene.
1991 Jul; 85(4):558. doi:
10.1016/0035-9203(91)90265-z. [PMID: 1755079] - P Mallmann, D Krebs. [The effect of adjuvant combined chemo/immunotherapy on immunological parameters and clinical course in patients with breast carcinoma].
Zentralblatt fur Gynakologie.
1991; 113(12):697-706. doi:
NULL. [PMID: 1927119] - L Di Stefano, D Facchini, A L De Paulis, F Cappa, M Moscarini. [Vulvar lesions caused by Papillomavirus (HPV): effectiveness of thymopentin (Syntomoduline). First results and experiences].
Minerva ginecologica.
1991 Jan; 43(1-2):53-6. doi:
NULL. [PMID: 1649422] - S Shiddo, I Ilardi, C Mussa, M A Mohamud, A Aceti, F Leone, A Sebastiani, Laghi, G Amiconi. Reinfection of Somali children with Trichuris trichiura after chemotherapy: relevance of immunostimulation.
Transactions of the Royal Society of Tropical Medicine and Hygiene.
1990 Nov; 84(6):832-6. doi:
10.1016/0035-9203(90)90100-s. [PMID: 2096517] - P Mallmann, D Krebs. Investigations on cell-mediated immunity in patients with breast and ovarian carcinomas receiving a combination of chemotherapy and immunotherapy with thymopentin.
Methods and findings in experimental and clinical pharmacology.
1990 Jun; 12(5):333-40. doi:
NULL. [PMID: 2232966] - V Klusa, R A Kiivet, R Muceniece, I Liepa, J Harro, S Svirskis, A Andermanis, L Rägo. Thymopentin antagonizes stress-induced changes of GABA/benzodiazepine receptor complex.
Regulatory peptides.
1990 Mar; 27(3):355-65. doi:
10.1016/0167-0115(90)90124-f. [PMID: 2158126] - W E Beyer, T C Noordzij, P Kramer, P P Diderich, C T Op den Hoek, J Janssen, N Masurel, W Weimar. Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis.
Nephron.
1990; 54(4):296-301. doi:
10.1159/000185883. [PMID: 2183079] - T A Deviatkina, V V Brechko, L M Tarasenko, I N Zviago'lskaia, Iu V Bezuglyĭ, I R Rituma, V E Klusha. [Correction of lipid peroxidation in stress with the peptide bioregulator thymopentin].
Fiziologicheskii zhurnal.
1989 Sep; 35(5):14-8. doi:
". [PMID: 2687033] - T A Deviatkina, L M Tarasenko, V E Klusha, O I Tsebrzhinskiĭ, R K Mutsenietse. [The protective action of thymopentin on stress damage to the stomach].
Biulleten' eksperimental'noi biologii i meditsiny.
1989 Jun; 107(6):673-5. doi:
". [PMID: 2676006] - V E Klusha, R K Mutsenietse, I R Liepa, Sh V Svirskis, A V Andermanis. [Thymus hormones--precursors of new psychoneuromodulatory peptides].
Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova.
1989 May; 75(5):691-6. doi:
NULL. [PMID: 2569989] - R S Pinals. Drug therapy in rheumatoid arthritis--a perspective.
British journal of rheumatology.
1989 Apr; 28(2):93-5. doi:
10.1093/rheumatology/28.2.93. [PMID: 2650801] - E L Ochoa, S Medrano, M C de Carlin, A M Dilonardo. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.
Cellular and molecular neurobiology.
1988 Sep; 8(3):325-31. doi:
10.1007/bf00711174. [PMID: 3066488] - V E Klusha, R K Mutsenietse, Sh V Svirskis, G M Zalitis, I R Liepa. [Neuroimmunoregulatory properties of short protein fragments in rats exposed to immobilization stress].
Biulleten' eksperimental'noi biologii i meditsiny.
1987 Aug; 104(8):186-7. doi:
NULL. [PMID: 2887222] - G A Heavner, D J Kroon, T Audhya, G Goldstein. Biologically active analogs of thymopentin with enhanced enzymatic stability.
Peptides.
1986 Nov; 7(6):1015-9. doi:
10.1016/0196-9781(86)90131-2. [PMID: 3031628] - T K Audhya, G Goldstein. Thymopentin: stability considerations and potency by various routes of administration.
Survey of immunologic research.
1985; 4 Suppl 1(?):17-23. doi:
10.1007/bf02919052. [PMID: 3898289] - J P Waymack, S Gonce, P Miskell, J W Alexander. Mechanisms of action of two new immunomodulators.
Archives of surgery (Chicago, Ill. : 1960).
1985 Jan; 120(1):43-8. doi:
10.1001/archsurg.1985.01390250037006. [PMID: 3917663] - M Fiorilli, I Quinti, G Russi, R Seminara, B Ensoli, F Aiuti. Thymopentin treatment of selective IgA deficiency.
Survey of immunologic research.
1985; 4 Suppl 1(?):129-34. doi:
10.1007/bf02919068. [PMID: 3898285] - T Audhya, G Goldstein. Comparative efficacy of various routes of administration of thymopentin (TP-5) with consideration of degradative mechanisms.
International journal of peptide and protein research.
1983 Aug; 22(2):187-93. doi:
10.1111/j.1399-3011.1983.tb02085.x. [PMID: 6352534] - L N Gastinel, J M Pleau, G Goldstein, J F Bach. Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS).
Thymus.
1983 Mar; 5(2):78-87. doi:
NULL. [PMID: 6304947] - K Kang, K D Cooper, J M Hanifin. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.
Journal of the American Academy of Dermatology.
1983 Mar; 8(3):372-7. doi:
10.1016/s0190-9622(83)70042-3. [PMID: 6339571] - K D Cooper, K Kang, J M Hanifin. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets.
Diagnostic immunology.
1983; 1(3):211-5. doi:
NULL. [PMID: 6388971] - R Yamanaka, R A Good, G S Incefy. Functional maturation difference between splenocytes that form autologous rosettes in adult thymectomized and aged mice.
Thymus.
1983; 5(1):35-42. doi:
NULL. [PMID: 6302958] - R C Williams, J D Montano, A D Bankhurst. Abrogation of in vitro suppressor cell activity in adult common variable hypogammaglobulinemia after TP5 treatment.
The Journal of laboratory and clinical medicine.
1983 Jan; 101(1):152-60. doi:
NULL. [PMID: 6217268] - S Ramagopal, G H Reem. Activities of purine nucleotide metabolizing enzymes in human thymocytes and peripheral blood T lymphocytes: in vitro effect of thymic hormones.
Thymus.
1982 May; 4(3):163-72. doi:
NULL. [PMID: 6287680] - O Strannegård, I L Strannegård, K Kang, K D Cooper, J M Hanifin. FcIgG receptor-bearing lymphocytes and monoclonal antibody-defined T cell subsets in atopic dermatitis: effect of treatment with thymopoietin pentapeptide (TP-5).
International archives of allergy and applied immunology.
1982; 69(3):238-44. doi:
10.1159/000233177. [PMID: 6752042] - M Fiorilli, M C Sirianni, F Pandolfi, I Quinti, U Tosti, F Aiuti, G Goldstein. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
Clinical and experimental immunology.
1981 Aug; 45(2):344-51. doi:
. [PMID: 7032772] - J P Tischio, J E Patrick, H S Weintraub, M Chasin, G Goldstein. Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma.
International journal of peptide and protein research.
1979; 14(5):479-84. doi:
10.1111/j.1399-3011.1979.tb01959.x. [PMID: 395119]